OTCMKTS:ULGX - 21st North Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.0070 0.00 (0.00 %) (As of 01/23/2019 04:25 AM ET)Previous Close$0.0070Today's Range$0.0062 - $0.007652-Week Range$0.0012 - $0.15Volume101,365 shsAverage Volume105,879 shsMarket Capitalization$152,726.00P/E RatioN/ADividend YieldN/ABeta5.99 ProfileDiscussionChartEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to benign prostatic hyperplasia (BPH) in the United States. The company offers Cooled ThermoTherapy, which produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort. It also provides Prostiva RF Therapy System that delivers radio frequency energy directly into the prostate to destroy prostate tissue, reduce constriction of the urethra, and relieve BPH symptoms. It serves patients and clinicians. Urologix, Inc. was founded in 1991 and is based in Minneapolis, Minnesota. Receive ULGX News and Ratings via Email Sign-up to receive the latest news and ratings for ULGX and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:ULGX Previous Symbol CUSIPN/A Webwww.urologix.com Phone612-475-1400Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares21,818,000Market Cap$152,726.00 OptionableNot Optionable 21st North (OTCMKTS:ULGX) Frequently Asked Questions What is 21st North's stock symbol? 21st North trades on the OTCMKTS under the ticker symbol "ULGX." Has 21st North been receiving favorable news coverage? News articles about ULGX stock have been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. 21st North earned a media sentiment score of 1.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next few days. Who are some of 21st North's key competitors? Some companies that are related to 21st North include Newcardio (NWCI), Reshape Lifesciences (RSLS), IMRIS (IMRSQ), Echo Therapeutics (ECTE), Fc Global Realty (FCRE), Helius Medical Technologies (HSDT), Nexeon Medsystems (NXNND), SpectraScience (SCIE) and Vision Sciences (CGNT). Who are 21st North's key executives? 21st North's management team includes the folowing people: Bryon Merade, Chairman & CEO How do I buy shares of 21st North? Shares of ULGX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is 21st North's stock price today? One share of ULGX stock can currently be purchased for approximately $0.0070. How big of a company is 21st North? 21st North has a market capitalization of $152,726.00. What is 21st North's official website? The official website for 21st North is http://www.urologix.com. How can I contact 21st North? 21st North's mailing address is 14405 21ST AVE N, MINNEAPOLIS MN, 55447. The company can be reached via phone at 612-475-1400 or via email at [email protected] MarketBeat Community Rating for 21st North (OTCMKTS ULGX)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 33 (Vote Outperform)Underperform Votes: 27 (Vote Underperform)Total Votes: 60MarketBeat's community ratings are surveys of what our community members think about 21st North and other stocks. Vote "Outperform" if you believe ULGX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ULGX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/23/2019 by MarketBeat.com StaffFeatured Article: How does inflation affect different investments?